Increasing resilience of medical supply chains during the COVID-19 pandemic
Why building future resilience requires a delicate balance between increased flexibility, efficiency and welfare advantages of GVCs.
Why building future resilience requires a delicate balance between increased flexibility, efficiency and welfare advantages of GVCs.
The recovery of supply chains can be supported through trade policies and firm-specific initiatives.
Women’s specific needs and potential as leaders and agents of change must be considered for COVID-19 mitigation and recovery measures.
COVID-19 struck at the core of GVC hub regions, with severe implications for international production networks.